Europe Irritable Bowel Syndrome (IBS) Diagnostics Market to Grow at a CAGR of 5.6% to reach US$ 1,191.44 million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increase in bowel's disease prevalence
5.1.2 Growth in demand for personalized therapeutics

5.2 Market Opportunities

5.2.1 Expansion in chronic disease management
5.2.2 Growth in the need for innovative treatments for bowel's disease

5.3 Future Trends

5.3.1 Increasing focus on precision medicine
5.3.2 Growth in advanced therapeutics for inflammatory bowel diseases

5.4 Impact of Drivers and Restraints

6. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Regional Analysis

6.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Overview

6.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue 2018-2028 (US$ Million)

6.3 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast Analysis

7. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – by Diagnosis

7.1 Laboratory Tests

7.1.1 Overview
7.1.2 Laboratory Tests: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Imaging Tests

7.2.1 Overview
7.2.2 Imaging Tests: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – by Indication

8.1 Pain & Cramping

8.1.1 Overview
8.1.2 Pain & Cramping: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Diarrhea

8.2.1 Overview
8.2.2 Diarrhea: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Constipation

8.3.1 Overview
8.3.2 Constipation: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Alternating Constipation & Diarrhea

8.4.1 Overview
8.4.2 Alternating Constipation & Diarrhea : Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Europe Analysis

9.1 Europe

9.1.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Key Country, 2021 and 2028 (%)
9.1.1.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast Analysis – by Country
9.1.1.1 UK: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 UK: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.1.1.1.2 UK: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

9.1.1.2 Germany: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Germany: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.1.1.2.2 Germany: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

9.1.1.3 France: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 France: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.1.1.3.2 France: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

9.1.1.4 Russia: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1 Russia: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.1.1.4.2 Russia: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

9.1.1.5 Italy: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.1 Italy: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.1.1.5.2 Italy: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

9.1.1.6 Rest of Europe: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1 Rest of Europe: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Diagnosis
9.1.1.6.2 Rest of Europe: Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Breakdown, by Indication

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Commonwealth Diagnostics International

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Genova Diagnostics

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Inova Diagnostics, Inc.

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Biohit Oyj

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Aerodiagnostics, LLC.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Sysmex Corporation (Sysmex Europe GmbH)

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 BÜHLMANN Laboratories AG

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

13. Appendix

13.1 About Business Market Insights